Pre-Annual General Meeting Information • Apr 3, 2019
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 9703U
ConvaTec Group PLC
03 April 2019
Notice of Annual General Meeting
READING, UNITED KINGDOM (3 April 2019) - ConvaTec Group Plc ("ConvaTec" or the "Group"), a global medical products and technologies company, has today published on the Group's website its Notice of Annual General Meeting (the "Notice of AGM"). The Notice of AGM is available at www.convatecgroup.com.
In compliance with Listing Rule 9.6.1, a copy of the Notice of AGM will also shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.
The Annual General Meeting will be held at 11 am on Thursday 9 May 2019 at The Concert Hall, Reading Town Hall, Blagrave Street, Reading RG1 1QH. Full details about the resolutions to be proposed and important information about the meeting are included within the Notice of AGM.
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
# # #
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
NOAUOOBRKNASRRR
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.